DrugsControl Media Services

News Detail

Boost in R&D investments generates higher ANDA approvals from US FDA (09-11-2023)

Mumbai, 9 Nov 2023: The Indian pharmaceutical industry is well set to establish strong presence in domestic and international markets with focus on research and development (R&D) activities. To overcome stiff competition and stringent approval norms in highly regulated market......
View Details

Source : Pharmabiz
Indian pharmaceutical industry research and development biosimilars complex generics biologics NCEs ANDA Zydus Pharma Aurobindo Pharma Eugia Pharma ANDAs Gland Pharma Mankind Pharma Hetero Labs Macleods Pharma Sun Pharma Taro Pharma Ajanta Pharma Alkem Labs Granules India Caplin Point Torrent Glenmark Pharma Natco Pharma Cadila Zydus Marksans Stride Pharma

Related News